Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
Pliaglis™ (lidocaine and tetracaine) Cream 7%/7% is a topical local anesthetic cream that
forms a pliable peel on the skin when exposed to air. When applied to intact skin, Pliaglis
provides local dermal analgesia by the release of lidocaine and tetracaine from the peel into
the skin.
Pliaglis is currently approved in the United States for use on intact skin in adults to
provide topical local analgesia for superficial dermatological procedures such as dermal
filler injection, pulsed dye laser therapy, and facial laser resurfacing.
This study will evaluate lidocaine and tetracaine cream 7%/7% for the treatment of pain
associated with postherpetic neuralgia (PHN).